| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 03/14/2002 | WO2002020012A2 Method for treating allergies using substituted pyrazoles |
| 03/14/2002 | WO2002019967A2 Substituted hydrazine derivatives |
| 03/14/2002 | WO2001062737A3 Amino pyrazole derivatives useful for the treatment of obesity and other disorders |
| 03/14/2002 | WO2001038302A3 Coupling condensation synthesis of heterocycles |
| 03/14/2002 | US20020032337 Halogenoarene reacted with a substituted alkyne, susbstituted arylalkyne formed is reacted with sodium hydroxide and then an acylating agent, and the arylalkinone formed is reacted with hydrazine |
| 03/14/2002 | US20020032336 Phenyl ketone derivative reacted with succinic anhydride andpotassium t-butoxide, diketone product reacted with hydrazine derivative to cause cyclization, esterification with ethanol and reacting with n-methylhydroxylamine hydrochloride |
| 03/14/2002 | US20020032238 Lowering the plasma level of atherogenic lipoproteins; treating hyperlipidaemias, atherosclerosis or the clinical sequelae thereof, diabetes mellitus, adiposity or pancreatitis |
| 03/14/2002 | US20020032227 Oxime derivative and bactericide containing the same as active ingredient |
| 03/14/2002 | US20020032202 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 03/14/2002 | US20020032198 Diaminopyrazoles |
| 03/14/2002 | US20020032193 3-substituted amino-4H-thieno(3, 2-e)-1,2,4-thiadiazine 1,1-dioxide is useful to protect the beta cells against toxic damage, for treating or preventing diseases related to autoimmune destruction of human beta cell |
| 03/14/2002 | US20020032186 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 03/14/2002 | US20020032184 For therapy of human immunodeficiency viral (HIV) , or genetically related retroviral, infection or a resulting acquired immunodeficiency syndrome (AIDS) |
| 03/14/2002 | US20020031536 Cosmetic compositions based on 4,5-pyrazolinediones, novel 4,5-pyrazolinediones, process for their preparation and uses thereof |
| 03/14/2002 | CA2422198A1 Substituted hydrazine derivatives |
| 03/14/2002 | CA2421505A1 Method for treating allergies using substituted pyrazoles |
| 03/14/2002 | CA2419966A1 Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor |
| 03/14/2002 | CA2419958A1 Substituted fused pyrroleimines and pyrazoleimines |
| 03/13/2002 | EP1185509A2 INHIBITORS OF FACTOR Xa |
| 03/13/2002 | EP1185508A2 Inhibitors of factor xa |
| 03/13/2002 | EP1185506A1 Substituted arylmalonic acid dinitriles as intermediates for the preparation of herbicides |
| 03/13/2002 | EP0983249B1 Processes and intermediates for preparing substituted indazole derivatives |
| 03/12/2002 | US6355799 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them |
| 03/12/2002 | US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents |
| 03/07/2002 | WO2002018347A1 Method for the production of n,n'-carbonyldiazoles and azolide salts |
| 03/07/2002 | WO2002018346A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | WO2002017923A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 03/07/2002 | WO2002017712A2 Disubstituted benzenes as insecticides |
| 03/07/2002 | WO2001089457A3 Thrombopoietin mimetics |
| 03/07/2002 | WO2001057022A3 Pyrazole compositions useful as inhibitors of erk |
| 03/07/2002 | WO2001042220A3 Podate ligands and methods of use thereof |
| 03/07/2002 | US20020028948 Process for preparing highly reactive (semi) crystalline and amorphous blocked polyisocyanates |
| 03/07/2002 | US20020028945 Non-steroidal antiinflammatory agent; enzyme sub-type specific; inhibits prostaglandin and/or leukotriene production |
| 03/07/2002 | US20020028933 Thioamide derivatives |
| 03/07/2002 | US20020028814 Aza compounds, pharmaceutical compositions and methods of use |
| 03/07/2002 | CA2420804A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 03/07/2002 | CA2420363A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 03/06/2002 | EP1184382A1 Oxime derivatives, process for the preparation thereof and pesticides |
| 03/06/2002 | EP1183235A2 INHIBITORS OF FACTOR Xa |
| 03/06/2002 | EP1183234A1 INHIBITORS OF FACTOR Xa |
| 03/06/2002 | EP1183229A1 Glucagon antagonists/inverse agonists |
| 03/06/2002 | EP1183019A2 Ace-2 inhibiting compounds and methods of use thereof |
| 03/06/2002 | CN1339027A New process for preparing pesticidal intermediates |
| 03/06/2002 | CN1338452A Substituted phenylamine derivatives |
| 03/06/2002 | CN1080257C Guanidine derivatives |
| 03/05/2002 | US6353117 Pyrazoline derivatives, their preparation and application as medicaments |
| 03/05/2002 | US6353116 Endothelin receptor antagonists |
| 03/05/2002 | CA2272138C Pyrazolopyrimidine and pyrazolopyridine compounds having crf antagonist activity |
| 02/28/2002 | WO2002016364A1 Polyethoxylated pyrazolo pyrimidinone derivatives, process for preparation thereof and pharmaceutical compositions comprising the same for the treatment of impotence |
| 02/28/2002 | WO2002016319A1 Novel thiourea compounds and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002015920A2 Treatment of hyperproliferative diseases |
| 02/28/2002 | WO2002015884A2 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | WO2001077080A3 Pyrazole compounds having anti proliferative activity |
| 02/28/2002 | WO2001046200A8 Novel piperidine and piperazine derivatives |
| 02/28/2002 | US20020025963 Novel guanidine mimics as factor Xa inhibitors |
| 02/28/2002 | US20020025910 3-heterocycly1 - substituted benzoyl derivatives |
| 02/28/2002 | CA2419840A1 Treatment of hyperproliferative diseases |
| 02/28/2002 | CA2419592A1 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 02/27/2002 | EP1182203A1 Azole compounds and herbicide compositions |
| 02/27/2002 | EP1181280A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides |
| 02/27/2002 | EP1181269A1 Cell proliferation inhibitors |
| 02/27/2002 | EP1181014A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 02/27/2002 | CN1337953A New thryoid receptor ligands and process II |
| 02/27/2002 | CN1337951A Process for preparing 1,5-diaryl-3-substituted pyrazoles |
| 02/27/2002 | CN1337949A Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid as TACE inhibitor |
| 02/27/2002 | CN1079794C Ether compound, use thereof, and intermediate for producing the compound |
| 02/26/2002 | US6350892 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors |
| 02/26/2002 | US6350771 Pesticidal 1-arylpyrazoles |
| 02/26/2002 | US6350749 Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof |
| 02/21/2002 | WO2002014314A2 Substituted pyrazoles |
| 02/21/2002 | WO2002014284A1 Processes for the preparation of pyrazole compounds |
| 02/21/2002 | WO2002014265A1 Novel 3-substituted urea derivatives and medicinal use thereof |
| 02/21/2002 | WO2001058869B1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 02/21/2002 | US20020022732 Reacting diether compound with acylating agent comprising acid anhydride or acid halide derivative to form pyrazole derivative |
| 02/21/2002 | US20020022575 Dialkyl-halogenophenyl-substituted ketoenols |
| 02/21/2002 | DE10135423A1 New 1-(2-chloro-1-(substituted carbonyloxy)-ethyl)-1H-pyrazole derivatives, useful as hydrolysis-resistant nitrification inhibitors for addition to ammonium and/or amide-containing fertilizers |
| 02/21/2002 | CA2419540A1 Substituted pyrazoles |
| 02/19/2002 | US6348480 Pharmaceutical compound comprising a pyrazole derivative and methods of using the same for the treatment of calcium release-activated calcium channel associated diseases |
| 02/19/2002 | US6348474 Compounds as antidiabetic agents |
| 02/14/2002 | WO2002012199A1 Heterocyclic mutilin esters and their use as antibacterials |
| 02/14/2002 | WO2002012197A1 1h-pyrazol derivatives, method for producing them and their use as nitrification inhibitors |
| 02/14/2002 | WO2002012165A1 (poly)ethereal ammonium salts of herbicides bearing acidic moieties and their use as herbicides |
| 02/14/2002 | WO2002011707A2 Drugs for incontinence |
| 02/14/2002 | WO2001070671A3 Insecticidal anthranilamides |
| 02/14/2002 | US20020019430 Nervous system and psychological disorders |
| 02/14/2002 | US20020019429 Antiarthritic agents; osteoporosis |
| 02/14/2002 | US20020019412 Antidiabetic agents |
| 02/14/2002 | US20020019408 New isoxazole-sulfonamide endothelin antagonists |
| 02/13/2002 | EP1178987A1 Substituted benzoylisoxazoles and the use thereof as herbicides |
| 02/13/2002 | CN1335836A Tricyclic pyrazole derivatives |
| 02/13/2002 | CN1335834A Aromatic heterocycle compounds having HIV integrase inhibiting activities |
| 02/13/2002 | CN1079097C Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives |
| 02/12/2002 | US6346542 Applying racemic mixture; controlling fleas and ticks; veterinary medicine |
| 02/12/2002 | US6346532 Antidiabetic, antilipemic, and hypoglycemic agents; adrenergic stimulants |
| 02/12/2002 | CA2053705C Piperazine derivatives |
| 02/07/2002 | WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | WO2002010137A2 Indazole derivatives as jnk inhibitors |
| 02/07/2002 | WO2002009759A2 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |